Litigation Details for Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd. (D. Del. 2017)
✉ Email this page to a colleague
Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd. (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-04-21 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 9,539,218 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd.
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Bayer Intellectual Property GMBH v. Taro Pharmaceutical Industries Ltd. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-07-12 | 102 | Stipulation-General (See Motion List for Stipulation to Extend Time) | Proposed] Order Regarding Infringement of U.S. Patent No. 9,539,218 by Sigmapharm Laboratories, LLC. (Myer, …21 April 2017 1:17-cv-00462-TBD 830 Patent None District Court, D. Delaware | External link to document |
| 2018-07-19 | 108 | Stipulation-General (See Motion List for Stipulation to Extend Time) | Proposed] Order Regarding Infringement of U.S. Patent No. 9,539,218 by InvaGen Pharmaceuticals, Inc.. (Myer,…21 April 2017 1:17-cv-00462-TBD 830 Patent None District Court, D. Delaware | External link to document |
| 2018-07-24 | 109 | Order | claims 1-4 of U.S. Patent No. 9,539,218 ("the Asserted Claims of the '218 Patent"), provided…and Order Regarding Infringement of U.S. Patent No. 9,539,218. Signed by Judge Richard G. Andrews on 7… INFRINGEMENT OF U.S. PATENT NO. 9,539,218 Plaintiff Bayer Intellectual Property…infringement of the Asserted Claims of the '218 Patent, provided the claim at issue is not proven invalid…infringement of the Asserted Claims of the '218 patent. 4. Nothing in this stipulation shall | External link to document |
| 2019-03-22 | 150 | Pretrial Order | assert all four claims of U.S. Patent No. 9,539,218 (“the ’218 patent”). 2. By letter dated…the ’218 patent. Plaintiffs timely filed complaints alleging infringement of the ’218 patent against …Legible, accurate copies of United States patents and foreign patents, as well as their corresponding prosecutions… 1. This is a consolidated action for patent infringement under the Hatch-Waxman Act. Plaintiffs…rivaroxaban tablets prior to the expiration of the ’218 patent. Mylan’s letter also notified BIP and Janssen | External link to document |
| 2019-04-02 | 157 | Opinion | tablet” in claims 1–4 of U.S. Patent No. 9,539,218 (“the ’218 patent”). Before the court are Joint Pretrial… to the expiration of the ’218 patent.1 Claim 1 of the ’218 patent recites: 1. A method of treating…012897, which is referenced in the ’218 patent. The ’218 patent specification states that “[p]reparation… reference.” ’218 patent, col. 8, ll. 28–30. Mylan points out that the patent cites “the wrong number…well-settled that, in a patent infringement suit, a district court can construe a patent to correct an obvious | External link to document |
| 2019-11-05 | 191 | Consent Judgment - Proposed | infringement of United States Patent No. 9,539,218 (“the ’218 patent”); WHEREAS Janssen currently…the term of the ’218 patent, including any patent term extensions and/or patent term adjustments and …prior to the expiration of the ’218 patent was a technical act of patent infringement with respect to the…prior to the expiration of the ’218 patent was a technical act of patent infringement with respect to the…’218 patent under 35 U.S.C. §271(e)(2)(A). 3. The asserted claims of the ’218 patent are | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
